跳至主要内容
临床试验/JPRN-jRCT2080220830
JPRN-jRCT2080220830未知3 期

A long-term extension study of AG-1749 in patients on concomitant long-term low-dose aspirin therapy

Takeda Pharmaceutical Company Limited0 个研究点开始时间: 2009年8月26日最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1. Patients who have finished the preceding confirmatory anti-ulcer efficacy study
  • 2. Patients who are on oral low-dose aspirin at the time of consent and who require continued long-term use of low-dose aspirin even after the start of study treatment in this study

排除标准

  • 未提供

研究者

相似试验